Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Carcinoma|Advanced Ovarian Carcinoma
Interventions: BIOLOGICAL: ONT-10, Varlilumab combination
Sponsor: Cascadian Therapeutics Inc.
Collaborators: Celldex Therapeutics